Zoetis Inc. Goodwill, Acquired During Period
Zoetis Inc. (ZTS) reported Goodwill, Acquired During Period of $38.00 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2023-11-02
- Zoetis Inc. goodwill, acquired during period for the quarter ending 2020-09-30 was $17.00M.
- Zoetis Inc. goodwill, acquired during period for the quarter ending 2019-03-31 was $0.00.
- Zoetis Inc. goodwill, acquired during period for the quarter ending 2017-10-01 was $7.00M.
- Zoetis Inc. goodwill, acquired during period for the quarter ending 2017-07-02 was $0.00.
- Zoetis Inc. goodwill, acquired during period for fiscal 2015 was $505.00M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2023-09-30 | $38.00M 10-Q · filed 2023-11-02 | |||
| 2020-09-30 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $69.00M 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | $52.00M 10-Q · filed 2020-08-06 | |||
| 2019-09-30 | $58.00M 10-Q · filed 2019-11-07 | |||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-02 | |||
| 2018-09-30 | $1.03B 10-Q · filed 2018-11-01 | |||
| 2017-10-01 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $7.00M derived: sum of 2 quarters · filed 2017-11-02 | $17.00M 10-Q · filed 2017-11-02 | |
| 2017-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $10.00M 10-Q · filed 2017-08-08 | ||
| 2017-04-02 | $10.00M 10-Q · filed 2017-05-04 | |||
| 2016-07-03 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $1.00M 10-Q · filed 2016-08-05 | $304.00M derived: sum of 3 quarters · filed 2016-08-05 | $306.00M derived: sum of 4 quarters · filed 2016-08-05 |
| 2016-04-03 | $2.00M 10-Q · filed 2016-05-06 | $305.00M derived: sum of 2 quarters · filed 2016-05-06 | $307.00M derived: sum of 3 quarters · filed 2016-05-06 | $307.00M derived: sum of 4 quarters · filed 2016-05-06 |
| 2015-12-31 | $303.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $305.00M derived: sum of 2 quarters · filed 2016-02-24 | $305.00M derived: sum of 3 quarters · filed 2016-02-24 | $505.00M 10-K · filed 2016-02-24 |
| 2015-09-27 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $2.00M derived: sum of 2 quarters · filed 2015-11-05 | $202.00M 10-Q · filed 2015-11-05 | |
| 2015-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $200.00M 10-Q · filed 2015-08-06 | ||
| 2015-03-29 | $200.00M 10-Q · filed 2015-05-07 | |||
| 2014-03-30 | $200.00M 10-Q · filed 2015-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |